In the News

Severe COVID-19 associated with more IBS, less constipation

A prospective multicenter study found that patients hospitalized for COVID-19 had significantly higher rates of irritable bowel syndrome (IBS) and fewer problems with constipation at 12 months than controls.

EoE patients with high BMI may be less likely to respond to topical corticosteroids

A retrospective cohort study of patients with eosinophilic esophagitis (EoE) found that each 1-point increase in body mass index (BMI) was associated with a 7% decrease in odds of histologic response to topical corticosteroids and that patients with obesity had about 40% odds of responding compared to those without.

RYGB associated with more alcohol-related hospitalizations than other weight-loss strategies

A recent cohort study compared hospitalizations related to alcohol use disorder and mortality among veterans who received Roux-en-Y gastric bypass (RYGB) surgery, sleeve gastrectomy, or referral to a weight management program.

MKSAP Quiz: Loose, bloody stools and rectal inflammation

This month's quiz asks readers to determine the most appropriate treatment for a 20-year-old patient with loose, bloody stools up to three times daily and moderate inflammatory mucosal changes involving the rectum.

Spotlight on pancreatic cancer risk

Recent studies assessed how use of dihydropyridine calcium-channel blockers, sustained exposure to hyperglycemia, recurrence of acute pancreatitis, and a range of dietary patterns may influence pancreatic cancer risk.

Response to linaclotide for IBS constipation can still appear after four weeks

An industry-funded analysis of four randomized trials of linaclotide for irritable bowel syndrome (IBS) with constipation found that improvement in abdominal and bowel symptoms occurred after four weeks of treatment in 1 in 6 and 1 in 10 patients, respectively.

FDA approves first fecal microbiota product

The product, which is prepared from donated, tested stool and administered rectally as a single dose, is indicated for the prevention of recurrent Clostridioides difficile infection in adults who have already completed antibiotic treatment for a recurrence.

Incontinence management system recalled due to potential interference with other devices

About a month after issuing an urgent medical device correction, the manufacturer announced a class I recall of the WatchCare Incontinence Management System due to potential radio frequency interference with other medical devices.

Annals On Call episode looks at benefits of sigmoidoscopy for CRC screening

A new episode of the podcast discussed a recent Annals study that assessed the 15-year benefits of sigmoidoscopy screening on colorectal cancer (CRC) incidence and mortality.

Case reports published on gastroenterology, hepatology topics

Reports on colitis remission, ruptured spontaneous hepatic subcapsular hematoma, esophageal varices secondary to pulmonary hypertension, and more were published in the past month.